60 results
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Outpatient Treatment ... with Community-Acquired ... fluoroquinolone #IDSA ... CAP #Community #Acquired ... #Antibiotics #Treatment
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Toxic Megacolon, Shock ... Epidemiology: • #1 ... can be community-acquired ... Ileus, Megacolon, Shock ... 10 mg/kg IV x 1
IDSA - Doses of Drugs for Treatment of Adults and Children with Multidrug-Resistant Tuberculosis
Step 1 Levofloxacin,
IDSA - Doses of ... Drugs for Treatment ... Tuberculosis Step 1 ... MDRTB #management #Treatment ... pharmacology #dosing #idsa
Asymptomatic Bacteriuria - IDSA Indications for Treatment
Healthy non-pregnant women - NO
Healthy pregnant women - YES
Functionally impaired
Bacteriuria - IDSA ... Indications for Treatment ... transplant - NO if > 1 ... If < 1 month) Patients ... #Bacteriuria #IDSA
Community Acquired Pneumonia - Severity and Prognosis
Criteria for Severe CAP - Severe CAP present in 1
Community Acquired ... CAP present in 1 ... criteria: Septic shock ... CAP #Community #Acquired
IDSA Surgical Wound Infection Algorithm
Algorithm for the management and treatment of surgical site infections (SSIs). 
*For
IDSA Surgical Wound ... management and treatment ... patients with type 1 ... Infection #Algorithm #IDSA
Shock - Differential Diagnosis Framework
 - MAP <65. SBP <90, drop in SBP > 40
 -
Shock - Differential ... Dehydration Shock ... Treatment Goals ... : 1) MAP > 60-65 ... criticalcare #algorithm #treatment
Community Acquired Pneumonia - Presenting Features
 • History in favor of CAP: Dyspnea, Cough, particularly if
Community Acquired ... complicated by septic shock ... CAP present in 1 ... criteria: Septic shock ... CAP #Community #Acquired
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
IDSA Treatment Recommendations ... mg per day) > 1 ... /kg per week) >1 ... Meningoencephalitis #IDSA ... #Treatment #management
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... 4–6 mL QID or 1– ... antifungals are required ... for effective treatment ... candida #mucosal #IDSA